Apiyasawat Sirin, Tangcharoen Tarinee, Wisaratapong Treechada, Yamwong Sukit, Wiboonpolprasert Suwit, Sritara Piyamitr
Division of Cardiology, Department of Medicine, Ramathibodi Hospital, Bangkok, Thailand.
Division of Cardiology, Department of Medicine, Ramathibodi Hospital, Bangkok, Thailand.
Int J Cardiol. 2015 Apr 15;185:293-6. doi: 10.1016/j.ijcard.2015.03.180. Epub 2015 Mar 17.
The outcome of patients hospitalized for atrial fibrillation (AF) is relatively poor. We sought to determine the mortality rate and predictors of mortality following hospitalization for AF and to evaluate whether the CHA2DS2-VASc score was a predictor of mortality.
We examined the national database of Thailand residents who registered for government provided health insurance in 2005 and reviewed patient records from 2005 to 2010 to determine all-cause mortality. A total of 8981 patients (mean age, 65 years; 42% male) were admitted to the hospital with a diagnosis of AF. Data on demographics and comorbidities were retrieved from the database. The CHA2DS2-VASc score was calculated for each patient.
The hospitalization rate for AF was 15.5 per 100,000 person-years. The two most common comorbidities were hypertension (N=1638, 18.2%) and diabetes (N=1349, 15.0%). The average CHA2DS2-VASc score for all patients was 1.8. By the 72-month follow-up (average 46 months), 3948 patients (44.0%) had died. The CHA2DS2-VASc score was directly related to the mortality rate (P log-rank <0.0001). Multivariate analysis showed that a CHA2DS2-VASc score ≥ 6 (hazard ratio [HR] 2.2, 95% confidence interval [CI], 1.4-3.7, P=0.002) and the presence of chronic kidney disease (HR 2.0, 95% CI 1.7-2.4, P<0.0001) were the strongest predictors of death.
The outcome after hospitalization for AF is relatively poor. The CHA2DS2-VASc score is an independent prognostic marker of poor outcomes following hospitalization for AF.
因心房颤动(AF)住院的患者预后相对较差。我们试图确定AF住院后的死亡率及死亡预测因素,并评估CHA2DS2-VASc评分是否为死亡预测因素。
我们查阅了2005年注册参加政府提供的健康保险的泰国居民的国家数据库,并回顾了2005年至2010年的患者记录以确定全因死亡率。共有8981例患者(平均年龄65岁;42%为男性)因AF诊断入院。从数据库中检索人口统计学和合并症数据。为每位患者计算CHA2DS2-VASc评分。
AF的住院率为每10万人年15.5例。两种最常见的合并症是高血压(N = 1638,18.2%)和糖尿病(N = 1349,15.0%)。所有患者的平均CHA2DS2-VASc评分为1.8。到72个月随访时(平均46个月),3948例患者(44.0%)死亡。CHA2DS2-VASc评分与死亡率直接相关(P对数秩检验<0.0001)。多变量分析显示,CHA2DS2-VASc评分≥6(风险比[HR]2.2,95%置信区间[CI],1.4 - 3.7,P = 0.002)和存在慢性肾病(HR 2.0,95%CI 1.7 - 2.4,P < 0.0001)是最强的死亡预测因素。
AF住院后的预后相对较差。CHA2DS2-VASc评分是AF住院后不良预后的独立预测指标。